Galectin-3: A potential target for cancer prevention

Trends in Carbohydrate Research

Volumn 3, Issue 2, 2011, Pages 12-21

  Ahmed, Hafiz ^a,b   Guha, Prasun ^a   Kaptan, Engin ^a,c   Bandyopadhyaya, Gargi ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Angiogenesis; Apoptosis; Galectin 3; TF disaccharide; Tumorigenesis

Indexed keywords

EID: 84861434447     PISSN: None     EISSN: 09750304     Source Type: Journal    
DOI: None     Document Type: Review

References (126)

1. Ahmed H, Du SJ, O'Leary N, Vasta GR, Biochemical and molecular characterization of galectins from zebrafish (Danio rerio): notochord-specific expression of a prototype galectin during early embryogenesis, Glycobiology 14, 2004, 219
2. Nakahara S, Raz A, Regulation of cancer-related gene expression by galectin-3 and the molecular mechanism of its nuclear import pathway, Cancer Metastasis Rev 26, 2007, 605
3. Rabinovich GA, Liu FT, Hirashima M, Anderson A, An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer, Scand J Immunol 66, 2007, 143
4. Nakahara S, Raz A, Biological modulation by lectins and their ligands in tumor progression and metastasis, Anticancer Agents MedChem 8, 2008, 22
5. Vasta GR, Roles of galectins in infection, Nat Rev Microbiol 7, 2009, 424
6. Elola MT, Wolfenstein-Todel C, Troncoso MF, Vasta GR, Rabinovich GA, Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival, Cell Mol Life Sci 64, 2007, 1679
7. Nakahara S, Oka N, Raz A, On the role of galectin-3 in cancer apoptosis, Apoptosis 10, 2005, 267
8. Dumic J, Dabelic S, Flogel M, Galectin-3: an open-ended story, Biochim Biophys Acta 1760, 2006, 616
9. Henderson NC, Sethi T, The regulation of inflammation by galectin-3, Immunol Rev 230, 2009, 160
10. Hsu DK, Chen HY, Liu FT, Galectin-3 regulates T-cell functions, Immunol Rev 230, 2009, 114
11. 2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells, Cancer Res 59 ,1999, 6239
12. Massa SM, Cooper DN, Leffler H, Barondes SH, L-29, an endogenous lectin, binds to glycoconjugate ligands with positive cooperativity, Biochemistry 32, 1993, 260
13. Yoshii T, Fukumori T, Honjo Y, Inohara H, Kim HR, Raz A, Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest, J Biol Chem 277, 2002, 6852
14. Ochieng J, Green B, Evans S, James O, Warfield P, Modulation of the biological functions of galectin-3 by matrix metalloproteinases, Biochim Biophys Actal 379, 1998, 97
15. Hsu DK, Zuberi RI, Liu FT, Biochemical and biophysical characterization of human recombinant IgE-binding protein, an S-type animal lectin, J Biol Chem 267, 1992, 14167
16. Ochieng J, Platt D, Tait L, Hogan V, Raz T, Carmi P, Raz A, Structure-function relationship of a recombinant human galactoside-binding protein, Biochemistry 32, 1993, 4455
17. Yang RY, Hsu DK, Liu FT, Expression of galectin-3 modulates T-cell growth and apoptosis, Proc Natl Acad Sci U S A 93, 1996, 6737
18. Yang RY, Hill PN, Hsu DK, Liu FT, Role of the carboxyl-terminal lectin domain in self-association of galectin-3, Biochemistry 37, 1998, 4086
19. Raimond J, Zimonjic DB, Mignon C, Mattel M, Popescu NC, Monsigny M, Legrand A. Mapping of the galectin-3 gene (LGALS3) to human chromosome 14at region 14q2122, Mamm Genome 8, 1997, 706.
20. Kadrofske MM, Openo KP, Wang JL, The human LGALS3 (galectin-3) gene: determination of the gene structure and functional characterization of the promoter, Arch Biochem Biophys 349, 1998, 7
21. Raimond J, Rouleux F, Monsigny M, Legrand A. The second intron of the human galectin-3 gene has a strong promoter activity down-regulated byp53, FEBSLett 363, 1995, 165.
22. Guittaut M, Charpentier S, Normand T, Dubois M, Raimond J, Legrand A. Identification of an internal gene to the human Galectin-3 gene with two different overlapping reading frames that do not encode Galectin-3, J Biol Chem 276, 2001, 2652.
23. M Duneau, M Boyer-Guittaut, P Gonzalez, S Charpentier, T Normand, M Dubois, J Raimond, A Legrand, Galig, a novel cell death gene that encodes a mitochondrial protein promoting cytochrome c release, Exp Cell Res 302, 2005, 194
24. Ahmed H, Allen HJ, Sharma A, Matta KL, Human splenic galaptin: carbohydrate-binding specificity and characterization of the combining site, Biochemistry 29, 1990, 5315
25. Ahmed H, Vasta GR, Galectins: conservation of functionally and structurally relevant amino acid residues defines two types of carbohydrate recognition domains, Glycobiology 4, 1994, 545
26. Ahmed H, Pohl J, Fink NE, Strobel F, Vasta GR, The primary structure and carbohydrate specificity of a 13-galactosyl-binding lectin from toad (Bufo arenarum Hensel) ovary reveal closer similarities to the mammalian galectin-1 than to the galectin from the clawed frog Xenopus laevis, J Biol Chem 271, 1996, 33083
27. Ahmed H, Fink NE, Pohl J, Vasta GR, Galectin-1 from bovine spleen: Biochemical characterization, carbohydrate specificity and tissue-specific isoform profiles, J Biochem (Tokyo) 120, 1996, 1007
28. Salomonsson E, Carlsson MC, Osla V, Hendus-Altenburger R, Kahl-Knutson B, Oberg CT, Sundin A, Nilsson R, Nordberg-Karlsson E, Nilsson UJ, Karlsson A, Rini JM, Leffler H, Mutational tuning of galectin-3 specificity and biological function, JBiol Chem 285, 2010, 35079
29. Liao DI, Kapadia G, Ahmed H, Vasta GR, Herzberg O, Structure of S-lectin, a developmentally regulated vertebrate beta-galactoside binding protein, Proc Natl Acad Sci USA 91, 1994, 1428
30. Bianchet MA, Ahmed H, Vasta GR, Amzel LM, A soluble 13-galactosyl-binding lectin (galectin) from toad (Bufo arenarum Hensel) ovary: Crystallographic studies of two protein-sugar complexes, Proteins 40, 2000, 378
31. Hirabayashi J, Kasai K, The family of metazoan metal-independent 13-galactoside-binding lectins: structure, function andmolecular evolution, Glycobiology 3, 1993, 297
32. Cooper DNW, Barondes SH, Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism, JCellBiol 110, 1990, 1681
33. Cho M, Cummings RD, Galectin-1, a ß-galactoside-binding lectin in Chinese hamster ovary cells, II. Localization and biosynthesis, JBiol Chem 270, 1995, 5207.
34. Barboni EA, Bawumia S, Hughes RC, Kinetic measurements of binding of galectin 3 to a laminin substratum, Glycoconj J 16, 1999, 365
35. Kariya Y, Kawamura C, Tabei T, Gu J, Bisecting GlcNAc residues on laminin-332 down-regulate galectin-3-dependent keratinocytemotility, JBiol Chem 285, 2010, 3330
36. Ochieng J, Leite-Browning ML, Warfield P, Regulation of cellular adhesion to extracellular matrix proteins by galectin-3, Biochem Biophys Res Commun, 246, 1998, 788
37. Fukumori T, Takenaka Y, Yoshii T, Kim HR, Hogan V, Inohara H, Kagawa S, Raz A, CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis, Cancer Res 63, 2003, 8302
38. Feuk-Lagerstedt E, Jordan ET, Leffler H, Dahlgren C, Karlsson A, Identification of CD66a and CD66b as the major galectin-3 receptor candidates in human neutrophils, J Immunol 163,1999, 5592
39. Rosenberg I, Cherayil BJ, Isselbacher KJ, Pillai S, Mac-2-binding glycoproteins. Putative ligands for a cytosolic beta-galactoside lectin, JBiol Chem 266, 1991, 18731.
40. Park JW, Voss PG, Grabski S, Wang JL, Patterson RJ, Association of galectin-1 and galectin-3 with Gemin4 in complexes containing the SMN protein, Nucleic Acids Res 29, 2001, 3595
41. Yang R-Y, Hsu DK, Liu F-T, Expression of galectin-3 modulates T cell growth and apoptosis, Proc Natl Acad Sci USA 93, 1996, 6737
42. Liu L, Sakai T, Sano N, Fukui K, Nucling mediates apoptosis by inhibiting expression of galectin-3 through interference with nuclear factor kappaB signalling, Biochem J 380,2 004, 31
43. Yu F, Finley RL Jr, Raz A, Kim HR, Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation, J Biol Chem 277 ,2002, 15819.
44. Shimura T, Takenaka Y, Tsutsumi S, Hogan V, Kikuchi A, Raz A, Galectin-3, a novel binding partner of beta-catenin, Cancer Res 64, 2004, 6363
45. Song S, Mazurek N, Liu C, Sun Y, Ding QQ, Liu K, Hung MC, Bresalier RS, Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity, Cancer Res, 69, 2009, 1343
46. Abedin MJ, Kashio Y, Seki M, Nakamura K, Hirashima M, Potential roles of galectins in myeloid differentiation into three different lineages, J Leukoc Biol 73, 2003, 650
47. Elliott MJ, Strasser A, Metcalf D. Selective up-regulation of macrophage function in granulocyte-macrophage colony-stimulating factor transgenic mice, J Immunol 147, 1991, 2957.
48. Reichert F, Rotshenker S. Galectin-3/MAC-2 in experimental allergic encephalomyelitis, ExpNeurol 160, 1999, 508.
49. Liu FT, Hsu DK, Zuberi RI, Kuwabara I, Chi EY, Henderson Jr EY. Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages, Am J Patholl 47, 1995, 1016.
50. Dabelic S, Flogel M, Dumic J. Effects of aspirin and indomethacin on galectin-3, Croat ChemActa 178, 2005, 433.
51. Dabelic S, Flogel M, Dumic J. Corticosteroids affect galectin-3 expression, Period Biol 107, 2005, 175.
52. Liu FT, Albrandt K, Mendel E, Kulczycki Jr A, Orida NK. Identification of an IgE-binding protein by molecular cloning, Proc Natl Acad Sci USA 82, 1985, 4100.
53. Joo HG, Goedegebuure PS, Sadanaga N, Nagoshi M, von Bernstorff W, Eberlein TJ. Expression and function of galectin-3, a beta- galactoside-binding protein in activated T lymphocytes, JLeukocBiol 69, 2001, 555.
54. Hebert E, Monsigny M. Galectin-3 mRNA level depends on transformation phenotype in ras-transformed NIH 3T3 cells, Biol Cell 81, 1994, 73.
55. Fogel S, Guittaut M, Legrand A, Monsigny M, Hebert E. The tat protein of HIV-1 induces galectin-3 expression, Glycobiology 9, 1999, 383.
56. Hsu DK, Hammes SR, Kuwabara I, Greene WC, Liu FT, Human T lymphotropic virus-I infection of human T lymphocytes induces expression of the beta-galactoside-binding lectin, galectin-3, Am JPathol 148, 1996, 1661
57. Dumic J, Lauc G, Flogel M. Expression of galectin-3 in cells exposed to stress-Roles of jun and NF-kappaB, Cell Physiol Biochem 10, 2000, 149.
58. Stock M, Schafer H, Strieker S, Gross G, Mundlos S, Otto F. Expression of galectin-3 in skeletal tissues is controlled by Runx2, J Biol Chem 278, 2003, 17360.
59. Costessi A, Pines A, D'Andrea P, Romanello M, Damante G, Cesaratto L, Quadrifoglio F, Moro L, Tell G. Extracellular nucleotides activate Runx2 in the osteoblast-like HOBIT cell line: a possible molecular link between mechanical stress and osteoblasts1 response, Bone 36, 2005, 418.
60. Ahmed H, Banerjee PB, Vasta GR, Differential expression of galectins in normal, benign and malignant prostate epithelial cells: Silencing of galectin-3 expression in prostate cancer by its promoter methylation, Biochem Biophys Res Commun 358, 2007, 241
61. Ruebel KH, Jin L, Qian X, Scheithauer BW, Kovacs K, Nakamura N, Zhang H, Raz A, Lloyd RV, Effects of DNA methylation on galectin-3 expression in pituitary tumors, Cancer Res 65, 2005, 1136
62. Ahmed, H, Cappello F, Rodolico V, Vasta GR, Evidence of heavy methylation in the galectin-3 promoter in early stages of prostate adenocarcinoma: Development and validation of a methylated marker for early diagnosis of prostate cancer, Trans Oncol 2, 2009, 146
63. Ahmed H, Promoter methylation in prostate cancer and its application for the early detection of prostate cancer using serum and urine samples, Biomarkers in Cancer 2, 2010, 17
64. Colnot C, Ripoche MA, Scaerou F, Foulis D, Poirier F, Galectins in mouse embryogenesis, Biochem Soc Trans 24, 1996, 141
65. Poirier F, Roles of galectins in vivo, Biochem Soc Symp 69, 2002, 95
66. Mercer N, Guzman L, Cueto Rua E, Drut R, Ahmed H, Vasta GR, Toscano MA, Rabinovich GA, Docena GH, Duodenal intraepithelial lymphocytes of children with cow milk allergy preferentially bind the glycan-binding protein galectin-3, Int J Immunopathol Pharmacol 22, 2009, 207
67. Dumont P, Berton A, Nagy N, Sandras F, Tinton S, Demetter P, Mascart F, Allaoui A, Decaestecker C, Salmon I, Expression of galectin-3 in the tumor immune response in colon cancer, Lab Invest 88, 2008, 896
68. Cao Z, Said N, Amin S, Wu HK, Bruce A, Garate M, Hsu DK, Kuwabara I, Liu FT, Panjwani N. Galectins-3 and -7, but not galectin-1, play a role in re-epithelialization of wounds, J Biol Chem 277, 2002, 42299.
69. Kaji Y, Amano S, Usui T, Oshika T, Yamashiro K, Ishida S, Suzuki K, Tanaka S, Adamis AP, Nagai R, Horiuchi S, Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells, Invest Ophthalmol Vis Sci 44, 2003, 521
70. Kang EH, Moon KC, Lee EY, Lee YJ, Lee EB, Ahn C, Song YW, Renal expression of galectin-3 in systemic lupus erythematosus patients with nephritis, Lupus 18, 2009, 22
71. Won YS, Jeong ES, Park HJ, Lee CH, Nam KH, Kim HC, Park JI, Choi YK, Upregulation of galectin-3 by Corynebacterium kutscheri infection in the rat lung, Exp Anim 56, 2007, 85
72. Silva-Monteiro E, Reis Lorenzato L, Kenji Nihei O, Junqueira M, Rabinovich GA, Hsu DK, Liu FT, Savino W, Chammas R, Villa-Verde DM, Altered expression of galectin-3 induces cortical thymocyte depletion and premature exit of immature thymocytes during Trypanosoma cruzi infection, Am J Pathol 170, 2007, 546
73. Shekhar MP, Nangia-Makker P, Tait L, Miller F, Raz A, Alterations in galectin-3 expression and distribution correlate with breast cancer progression: functional analysis of galectin-3 in breast epithelial-endothelial interactions, Am J Pathol 165, 2004, 1931
74. Pacis RA, Pilat MJ, Pienta KJ, Wojno K, Raz A, Hogan V, Cooper CR. Decreased galectin-3 expression in prostate cancer, Prostate, 44, 2000, 118.
75. Xu XC, Sola Gallego JJ, Lotan R, El-Naggar AK. Differential expression of galectin-1 and galectin-3 in benign and malignant salivary gland neoplasms, Int J Oncol 17, 2000, 271.
76. Wang L, Friess H, Zhu Z, Frigeri L, Zimmermann A, Korc M, Berberat PO, Buchler MW. Galectin-1 and galectin-3 in chronic pancreatitis, Lab Invest 80, 2000, 1233.
77. Sasaki S, Bao Q, Hughes RC. Galectin-3 modulates rat mesangial cell proliferation and matrix synthesis during experimental glomerulonephritis induced by anti-Thyl.l antibodies, J Pathol 187, 1999, 481.
78. Fautsch MP, Silva AO, Johnson DH. Carbohydrate binding proteins galectin-1 and galectin-3 in human trabecular meshwork, Exp Eye Res 77, 2003, 11.
79. Shimonishi T, Miyazaki K, Kono N, Sabit H, Tuneyama K, Harada K, Hirabayashi J, Kasai K, Nakanuma Y. Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma, Hum Pathol 32, 2001, 302
80. Moutsatsos IK, Wade M, Schindler M, Wang JL. Endogenous lectins from cultured cells: nuclear localization of carbohydrate-binding protein 35 in proliferating 3T3 fibroblasts, Proc Natl AcadSciUSA 84, 1987, 6452.
81. Niida S, Amizuka N, Hara F, Ozawa H, Kodama H. Expression of Mac-2 antigen in the preosteoclast and osteoclast identified in the op/op mouse injected with macrophage colony-stimulating factor, J Bone Miner Res 9, 1994, 873.
82. Wollenberg A, de la Salle H, Hanau D, Liu FT, Bieber T. Human keratinocytes release the endogenous beta-galactoside-binding soluble lectin immunoglobulin E (IgE-binding protein) which binds to Langerhans cells where it modulates their binding capacity for IgE glycoforms, J Exp Med 178, 1993, 777.
83. Reichert F, Saada A, Rotshenker S. Peripheral nerve injury induces Schwann cells to express two macrophage phenotypes: phagocytosis and the galactose-specific lectin MAC-2, J Neurosci 14, 1994, 3231.
84. Lotan R, Ito H, Yasui W, Yokozaki H, Lotan D, Tahara E. Expression of a 31-kDa lactoside-binding lectin in normal human gastric mucosa and in primary and metastatic gastric carcinomas, Int J Cancer 56, 1994, 474.
85. Lotan R, Belloni PN, TresslerRJ, Lotan D, Xu XC, Nicolson GL. Expression of galectins on microvessel endothelial cells and their involvement in tumour cell adhesion, Glycoconj J 11, 1994, 462.
86. Truong MJ, Gruart V, Kusnierz JP, Papin JP, Loiseau S, Capron A, Capron M. Human neutrophils express immunoglobulin E (IgE)-binding proteins (Mac-2/epsilon BP) of the S-type lectin family: role in IgE dependent activation, J Exp Med 177, 1993, 243.
87. Truong MJ, Gruart V, Liu FT, Prin L, Capron A, Capron M. IgEbinding molecules (Mac-2/epsilon BP) expressed by human eosinophils. Implication in IgE-dependent eosinophil cytotoxicity, Eur J Immunol 23, 1993, 3230.
88. Craig SS, Krishnaswamy P, Irani AM, Kepley CL, Liu FT, Schwartz LB. Immunoelectron microscopic localization of galectin-3, an IgE binding protein, in human mast cells and basophils, Anat Rec 242, 1995, 211.
89. Smetana K, Holikova Z, Klubal R, Bovin NV, Dvorankova B, Bartunkova J, Liu FT, Gabius HJ. Coexpression of binding sites for A (B) histo-blood group trisaccharides with galectin-3 and Lag antigen in human Langerhans cells, J Leukoc Biol 66, 1999, 644.
90. Dietz AB, Bulur PA, Knutson GJ, Matasic R, Vuk-Pavlovic S. Maturation of human monocyte-derived dendritic cells studied by microarray hybridization. Biochem. Biophys, Res Commun 275, 2000, 731.
91. Saada A, Reichert F, Rotshenker S. Granulocyte macrophage colony stimulating factor produced in lesioned peripheral nerves induces the upregulation of cell surface expression of MAC-2 by macrophages and Schwann cells, J Cell Biol 133, 1996, 159.
92. Liu FT, Rabinovich GA, Galectins as modulators of tumour progression, Nat Rev Cancer 5, 2005, 29
93. Song YK, Billiar TR, Lee YJ, Role of galectin-3 in breast cancer metastasis: involvement of nitric oxide. Am J Pathol 160, 2002, 1069.
94. Bresalier RS, Yan PS, Byrd JC, Lotan R, Raz A, Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system, Cancer 80, 1997, 776
95. Hsu DK, Dowling CA, Jeng KC, Chen JT, Yang RY, Liu FT, Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma. Int J Cancer 81, 1999, 519.
96. Miyazaki J, Hokari R, Kato S, Tsuzuki Y, Kawaguchi A, Nagao S, Itoh K, Miura S, Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes, Oncol Rep 9, 2002, 1307
97. Yoshimura A, Gemma A, Hosoya Y, Komaki E, Hosomi Y, Okano T, Takenaka K, Matuda K, Seike M, Uematsu K, Hibino S, Shibuya M, Yamada T, Hirohashi S, Kudoh S, Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer, Genes Chromosomes Cancer 37, 2003, 59
98. Merseburger AS, Kramer MW, Hennenlotter J, Simon P, Knapp J, Hartmann JT, Stenzl A, Serth J, Kuczyk MA, Involvement of decreased galectin-3 expression in the pathogenesis and progression of prostate cancer, Prostate 68, 2008, 72
99. Merseburger AS, Kramer MW, Hennenlotter J, Serth J, Kruck S, GraciaA, Stenzl A, Kuczyk MA, Loss of galectin-3 expression correlates with clear cell renal carcinoma progression and reduced survival, World JUrol 26, 2008, 637
100. Van den Brule FA, Waltregny D, Liu FT, Castronovo V, Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression, Int J Cancer 89, 2000, 361
101. Takenaka Y, Fukumori T, Yoshii T, Oka N, Inohara H, Kim HR, Bresalier RS, Raz A, Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs, Mol Cell Biol 24, 2004, 4395
102. Elad-Sfadia G, Haklai R, Balan E, KloogY, Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity, J Biol Chem 279, 2004, 34922
103. Burlacu A, Regulation of apoptosis by Bcl-2 family proteins, J Cell Mol Med 7, 2003, 249
104. Moon BK, Lee YJ, Battle P, Jessup JM, Raz A, Kim HR, Galectin-3 protects human breast carcinoma cells against nitric oxide-induced apoptosis: implication of galectin-3 function during metastasis, Am J Pathol 159, 2001, 1055
105. Yu F, Finley RL Jr, Raz A, Kim HR, Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. Arole for synexin in galectin-3 translocation, J Biol Chem 277, 2002, 15819.
106. Hsu DK, Chen HY, Liu FT, Galectin-3 regulates T-cell functions. Immunol Rev 230, 2009, 114.
107. Li W, Jian-jun W, Xue-Feng Z, Feng Z, CD133(+) human pulmonary adenocarcinoma cells induce apoptosis of CD8(+) T cells by highly expressed galectin-3, Clin Invest Med 33, 2010, E44
108. Nangia-Makker P, Balan V, Raz A, Regulation of tumor progression by extracellular galectin-3, Cancer Microenviron 1, 2008, 43
109. Ashkenazi A, Dixit VM, Death receptors: signaling and modulation, Science 281, 1998, 1305
110. Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME, Apoptosis signaling by death receptors, Eur J Biochem 254, 1998, 439
111. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME. Two CD95 (APO-1/Fas) signaling pathways, EMBO J 17, 1998, 1675.
112. Barnhart BC, Alappat EC, Peter ME, The CD95 type I/type II model, Semin Immunol 15, 2003, 185
113. Fukumori T, Takenaka Y, OkaN, Yoshii T, HoganV, Inohara H, Kanayama HO, Kim HR, Raz A, Endogenous galectin-3 determines the routing of CD95 apoptotic signaling pathways, Cancer Res 64, 2004, 3376
114. Inohara H, Raz A, Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion, Cancer Res 55, 1995, 3267
115. Inohara H, Akahani S, Koths K, Raz A, Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion. Cancer Res 56, 1996, 4530.
116. Al-Mehdi AB, Tozawa K, Fisher AB, Shientag L, Lee A, Muschel RJ. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis, Nat Med 6, 2000, 100.
117. Yu LG, The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression, Glycoconj J 24, 2007, 411
118. Yu LG, Andrews N, Zhao Q, McKean D, Williams JF, Connor LJ, Gerasimenko OV, Hilkens J, Hirabayashi J, Kasai K, Rhodes JM, Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion, J Biol Chem 282, 2007, 773
119. Glinsky VV, Glinsky GV, Rittenhouse-Olson K, Huflejt ME, Glinskii OV, Deutscher SL, Quinn TP, The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium, Cancer Res 61, 2001, 4851
120. Zhao Q, Barclay M, Hilkens J, Guo X, Barrow H, Rhodes JM, Yu LG, Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis, Mol Cancer 9, 2010, 154
121. Yu LG, Circulating galectin-3 in the bloodstream: An emerging promoter of cancer metastasis, World J Gastrointest Oncol 2, 2010, 177
122. Califice S, Castronovo V, Bracke M, van den Brule F, Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3, Oncogene 23, 2004, 7527
123. Glinsky VV, Raz A, Modified citrus pectin anti-metastatic properties: one bullet, multiple targets, Carbohydr Res 344, 2009, 1788
124. Pienta KJ, Naik H, Akhtar A, Yamazaki K, Replogle TS, Lehr J, Donat TL, Tait L, Hogan V, Raz A, Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration ofmodi fied citrus pectin, JNatl Cancer Inst 87, 1995, 348
125. Glinskii OV, Huxley VH, Glinsky GV, Pienta KJ, Raz A, Glinsky W, Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs, Neoplasia7, 2005, 522
126. Prasun Guha, Engin Kaptan, Gargi Bandyopadhyaya, Dhan Kalvakolanu, Gerardo R. Vasta, and Hafiz Ahmed. Natural Thomsen-Friedenreich disaccharide (TFD) containing compound prevents galectin-3-mediated tumor-endothelial cell adhesion, angiogenesis, andT-cell apoptosis (Submitted).